bioMérieux S.A.

WBAG:BIM Stock Report

Market Cap: €12.0b

bioMérieux Past Earnings Performance

Past criteria checks 4/6

bioMérieux has been growing earnings at an average annual rate of 6.3%, while the Medical Equipment industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 7.8% per year. bioMérieux's return on equity is 10.3%, and it has net margins of 10.8%.

Key information

6.3%

Earnings growth rate

6.4%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate7.8%
Return on equity10.3%
Net Margin10.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How bioMérieux makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

WBAG:BIM Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 243,8074111,055474
31 Mar 243,7413841,038467
31 Dec 233,6753581,021460
30 Sep 233,6883721,019463
30 Jun 233,7013861,017466
31 Mar 233,645419986456
31 Dec 223,589452955447
30 Sep 223,525502916429
30 Jun 223,460552877412
31 Mar 223,418577846399
31 Dec 213,376601816386
30 Sep 213,296555801381
30 Jun 213,216509786377
31 Mar 213,167457788388
31 Dec 203,118404789399
30 Sep 202,997355784399
30 Jun 202,876305778398
31 Mar 202,775289764386
31 Dec 192,675273750374
30 Sep 192,601268721362
30 Jun 192,527263693350
31 Mar 192,474260668338
31 Dec 182,421257643327
30 Sep 182,372264626320
30 Jun 182,323271609312
31 Mar 182,306255607308
31 Dec 172,288238604304
30 Sep 172,262216604300
30 Jun 172,237195604295
31 Mar 172,170187587283
31 Dec 162,103179570272
30 Sep 162,068158555260
30 Jun 162,032137540249
31 Mar 161,998124534244
31 Dec 151,965111529239
30 Sep 151,908127510230
30 Jun 151,851144492222
31 Mar 151,775140472214
31 Dec 141,698135453206
30 Sep 141,656135437201
30 Jun 141,614135422196
31 Mar 141,601150413191
31 Dec 131,588164405186

Quality Earnings: BIM has high quality earnings.

Growing Profit Margin: BIM's current net profit margins (10.8%) are higher than last year (10.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BIM's earnings have grown by 6.3% per year over the past 5 years.

Accelerating Growth: BIM's earnings growth over the past year (6.6%) exceeds its 5-year average (6.3% per year).

Earnings vs Industry: BIM earnings growth over the past year (6.6%) did not outperform the Medical Equipment industry 12.5%.

Return on Equity

High ROE: BIM's Return on Equity (10.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 08:04
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

bioMérieux S.A. is covered by 35 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Armelle MoulinAlphaValue
Gaurav JainBarclays
Samuel EnglandBerenberg